Search Results

There are 18240 results for: content related to: Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects

  1. You have free access to this content
    Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes

    British Journal of Clinical Pharmacology

    Volume 70, Issue 3, September 2010, Pages: 383–392, Takahisa Furuta, Takayuki Iwaki and Kazuo Umemura

    Version of Record online : 1 JUN 2010, DOI: 10.1111/j.1365-2125.2010.03717.x

  2. You have free access to this content
    The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes

    British Journal of Clinical Pharmacology

    Volume 81, Issue 2, February 2016, Pages: 301–312, Ho-Sook Kim, Younghae Lim, Minkyung Oh, Jong-lyul Ghim, Eun-Young Kim, Dong-Hyun Kim and Jae-Gook Shin

    Version of Record online : 28 DEC 2015, DOI: 10.1111/bcp.12794

  3. You have free access to this content
    Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

    Clinical Pharmacology & Therapeutics

    Volume 94, Issue 3, September 2013, Pages: 317–323, S A Scott, K Sangkuhl, C M Stein, J-S Hulot, J L Mega, D M Roden, T E Klein, M S Sabatine, J A Johnson and A R Shuldiner

    Version of Record online : 22 MAY 2013, DOI: 10.1038/clpt.2013.105

    This article corrects:
  4. CYP2C19*17 increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel

    Clinical and Experimental Pharmacology and Physiology

    Volume 41, Issue 11, November 2014, Pages: 870–878, Rasmus Steen Pedersen, Flemming Nielsen, Tore Bjerregaard Stage, Pernille Just Vinholt, Alaa Bilal el Achwah, Per Damkier and Kim Brosen

    Version of Record online : 26 NOV 2014, DOI: 10.1111/1440-1681.12297

  5. Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms

    The Journal of Clinical Pharmacology

    Volume 49, Issue 5, May 2009, Pages: 574–581, Dr B. L. Chen, Dr Y. Chen, Dr J. H. Tu, Dr Y. L. Li, Dr W. Zhang, Dr Q. Li, Dr L. Fan, Dr Z. R. Tan, Dr D. L. Hu, Dr D. Wang, Dr L. S. Wang, Dr D. S. OuYang and Dr H. H. Zhou

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009333016

  6. Differential Impacts of CYP2C19 Gene Polymorphisms on the Antiplatelet Effects of Clopidogrel and Ticlopidine

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 2, February 2011, Pages: 229–233, A Maeda, H Ando, T Asai, H Ishiguro, N Umemoto, M Ohta, M Morishima, A Sumida, T Kobayashi, K Hosohata, K Ushijima and A Fujimura

    Version of Record online : 22 DEC 2010, DOI: 10.1038/clpt.2010.268

  7. Personalizing Antiplatelet Therapy With Clopidogrel

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 4, October 2012, Pages: 476–485, D Trenk, O Zolk, M F Fromm, F-J Neumann and W Hochholzer

    Version of Record online : 5 SEP 2012, DOI: 10.1038/clpt.2012.133

  8. The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 2, August 2008, Pages: 236–242, KA Kim, PW Park, SJ Hong and J-Y Park

    Version of Record online : 5 MAR 2008, DOI: 10.1038/clpt.2008.20

  9. You have free access to this content
    The effect of CYP2C19 genotype on the time course of platelet aggregation inhibition after clopidogrel administration

    The Journal of Clinical Pharmacology

    Volume 54, Issue 8, August 2014, Pages: 850–857, Ho-Sook Kim, Doo-Yeoun Cho, Bo-Min Park, Soo-Kyoung Bae, Yune-Jung Yoon, Minkyung Oh, Jong-lyul Ghim, Eun-Young Kim, Dong-Hyun Kim and Jae-Gook Shin

    Version of Record online : 26 NOV 2013, DOI: 10.1002/jcph.225

  10. Influence of CYP2C19 loss-of-function variants on the metabolism of clopidogrel in patients from north-western China

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 3, June 2015, Pages: 308–314, R. Lin, L. Zhang, P. Zhang, L. Zhou, T. Liu, Y. Li, W. Zhang, W. Wang and J. Zhang

    Version of Record online : 24 MAR 2015, DOI: 10.1111/jcpt.12254

  11. You have free access to this content
    Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 2, August 2011, Pages: 328–332, SA Scott, K Sangkuhl, EE Gardner, CM Stein, J-S Hulot, JA Johnson, DM Roden, TE Klein and AR Shuldiner

    Version of Record online : 29 JUN 2011, DOI: 10.1038/clpt.2011.132

    Corrected by:

    CPIC Update: Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

    Vol. 94, Issue 3, 317–323, Version of Record online: 22 MAY 2013

  12. You have free access to this content
    Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 8, August 2010, Pages: 1678–1684, M. J. SORICH, A. VITRY, M. B. WARD, J. D. HOROWITZ and R. A. MCKINNON

    Version of Record online : 21 MAY 2010, DOI: 10.1111/j.1538-7836.2010.03923.x

  13. INHIBITION OF ADP-INDUCED PLATELET AGGREGATION BY CLOPIDOGREL IS RELATED TO CYP2C19 GENETIC POLYMORPHISMS

    Clinical and Experimental Pharmacology and Physiology

    Volume 35, Issue 8, August 2008, Pages: 904–908, Bi-Lian Chen, Wei Zhang, Qing Li, Ya-Lin Li, Yi-Jing He, Lan Fan, Lian-Sheng Wang, Zhao-Qian Liu and Hong-Hao Zhou

    Version of Record online : 13 MAR 2008, DOI: 10.1111/j.1440-1681.2008.04915.x

  14. You have free access to this content
    Pharmacogenomics in cardiovascular disease: focus on aspirin and ADP receptor antagonists

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 9, September 2013, Pages: 1627–1639, M. Würtz, M. Lordkipanidzé and E. L. Grove

    Version of Record online : 12 SEP 2013, DOI: 10.1111/jth.12318

  15. You have free access to this content
    Distribution of CYP2C19*17 allele and genotypes in an Indian population

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 3, June 2012, Pages: 313–318, D. Anichavezhi, U. S. Chakradhara Rao, D. G. Shewade, R. Krishnamoorthy and C. Adithan

    Version of Record online : 15 SEP 2011, DOI: 10.1111/j.1365-2710.2011.01294.x

  16. Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 3, March 2011, Pages: 455–459, AL Beitelshees, RB Horenstein, MR Vesely, MR Mehra and AR Shuldiner

    Version of Record online : 26 JAN 2011, DOI: 10.1038/clpt.2010.316

  17. Pharmacogenomics: Application to the Management of Cardiovascular Disease

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 4, October 2011, Pages: 519–531, J A Johnson, L H Cavallari, A L Beitelshees, J P Lewis, A R Shuldiner and D M Roden

    Version of Record online : 14 SEP 2011, DOI: 10.1038/clpt.2011.179

  18. You have free access to this content
    The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro

    British Journal of Pharmacology

    Volume 166, Issue 8, August 2012, Pages: 2362–2370, V Ancrenaz, J Desmeules, R James, P Fontana, J-L Reny, P Dayer and Y Daali

    Version of Record online : 24 JUL 2012, DOI: 10.1111/j.1476-5381.2012.01946.x

  19. You have free access to this content
    Genetics of platelet inhibitor treatment

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 642–653, Dietmar Trenk and Willibald Hochholzer

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12230

  20. Non-antiplatelet effect of clopidogrel: improving endothelial function in Chinese healthy subjects with different CYP2C19 genotype

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 1, January 2015, Pages: 22–26, Yin-Zhuang Zhang, Bi-Lian Chen, Wei Zhang and Xin Cao

    Version of Record online : 22 DEC 2014, DOI: 10.1111/1440-1681.12325